ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

December 30, 2011

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

In Brief: “The Journal” to Mae its Appearance In Jan., With Wittes As Editor; Manuscripts Solicited

October 16, 1987

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001